RO3
CAS No. 1026582-88-6
RO3( —— )
Catalog No. M22083 CAS No. 1026582-88-6
RO3 is a selective antagonist of homomeric P2X3 and heteromeric P2X2/3 receptor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 222 | In Stock |
|
| 10MG | 335 | In Stock |
|
| 25MG | 566 | In Stock |
|
| 50MG | 806 | In Stock |
|
| 100MG | 1098 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameRO3
-
NoteResearch use only, not for human use.
-
Brief DescriptionRO3 is a selective antagonist of homomeric P2X3 and heteromeric P2X2/3 receptor.
-
DescriptionRO3 is a selective antagonist of homomeric P2X3 and heteromeric P2X2/3 receptor.
-
In Vitro——
-
In VivoIn a guinea pig ureter-afferent nerve preparation, and mouse bladder-pelvic nerve preparation, RO-3 dose-dependently reduces afferent nerve activity induced by distension or α,β-meATP.RO-3 has activity in several rodent models of pain, as well as in cystometry models optimized to measure various parameters associated with sensory regulation of the micturition reflex.RO-3 has moderate to high metabolic stability in rat and human hepatocytes and liver microsomes, and is highly permeable, orally bioavailable (14%), and has a reasonable in vivo plasma half-life (t1/2=0.41?h) in rats.
-
Synonyms——
-
PathwayNeuroscience
-
TargetP2 Receptor
-
RecptorP2X3
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1026582-88-6
-
Formula Weight302.38
-
Molecular FormulaC16H22N4O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (413.40 mM)
-
SMILESCOc1cc(Cc2cnc(N)nc2N)c(cc1OC)C(C)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Gever J R , Cockayne D A , Dillon M P , et al. Pharmacology of P2X channels[J]. Pflügers Archiv European Journal of Physiology, 2006, 452(5):513-37.
molnova catalog
related products
-
Diquafosol tetrasodi...
Diquafosol Tetrasodium is a P2Y2 receptor agonist that stimulates the secretion of mucins from ocular tissues Diquafosol tetrasodium improves tear film stability and visual function?as a topical treatment of dry eye disease.
-
TAPI-1 trifluoroacet...
TAPI-1 is an ADAM17/TACE inhibitor, which blocks shedding of cytokine receptors.
-
Prasugrel
Prasugrel, a thienopyridine derivative, is a platelet activation and aggregation inhibitor structurally and pharmacologically related to clopidogrel and ticlopidine.
Cart
sales@molnova.com